AR and prostate carcinoma: A study on prostate cancer demonstrated that betulin significantly downregulated SREBP2 and its target genes, exhibiting inhibitory effects on the downstream activity of the androgen receptor (AR), which suppressed prostate cancer progression (Wei et al., 2024).